Company Filing History:
2 out of 1,217 
1 out of 289 
Years Active: 1995-2000
Title: Maribeth V Eiden: Innovator in Retroviral Research
Introduction
Maribeth V Eiden is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of retroviral research, particularly in the development of innovative retroviral vectors. With a total of 2 patents, her work has had a substantial impact on medical research and therapeutic applications.
Latest Patents
Among her latest patents, Maribeth V Eiden has developed retroviral vectors based on the gibbon ape leukemia virus. These patents include retrovirus packaging and producer cell lines, specifically PG13 (ATCC No. CRL 10686) and PG13/LNc8 (ATCC No. CRL 10685). The retroviruses packaged by these cells are crucial for advancing research in gene therapy and other medical applications.
Career Highlights
Throughout her career, Maribeth has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Fred Hutchinson Cancer Center. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Maribeth has collaborated with notable colleagues, including Carolyn A Wilson and Nicholas John Deacon. These partnerships have further enhanced her research and innovation in retroviral technology.
Conclusion
Maribeth V Eiden's contributions to retroviral research exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in her field.